Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted TherapyJens G. Lohr, Keith Stockerl-Goldstein, Joshua Gould et al.|Cancer Cell|2014Cited by 1k
Lenalidomide for the Treatment of Cryoglobulinemia and Undifferentiated Spondyloarthropathy in a Patient With Multiple MyelomaRichard J. Lin, Nadera Sweiss, James J. Curran et al.|JCR Journal of Clinical Rheumatology|2010Cited by 10
Cost-effectiveness of zanubrutinib versus ibrutinib in adult patients with Waldenström macroglobulinemia in the United States.Jorge J. Castillo, Boxiong Tang, Keri Yang et al.|Journal of Clinical Oncology|2021Cited by 6
Efficacy and safety of zanubrutinib versus rituximab-based chemoimmunotherapy in Waldenström macroglobulinemia (WM): Matching-adjusted indirect comparisons.Jorge J. Castillo, Boxiong Tang, Keri Yang et al.|Journal of Clinical Oncology|2021Cited by 2